Effect of alendronate or 8-prenylnaringenin applied as a single therapy or in combination with vibration on muscle structure and bone healing in ovariectomized rats

被引:9
|
作者
Komrakova, M. [1 ]
Rechholtz, C. [1 ]
Pohlmann, N. [1 ]
Lehmann, W. [1 ]
Schilling, A. F. [1 ]
Wigger, R. [2 ]
Sehmisch, S. [1 ]
Hoffmann, D. B. [1 ]
机构
[1] Univ Med Ctr Goettingen, Dept Trauma Surg Orthopaed & Plast Surg, Robert Koch Str 40, D-37075 Gottingen, Germany
[2] Univ Goettingen, Dept Anim Sci, Albrecht Thaer Weg 3, D-37075 Gottingen, Germany
来源
BONE REPORTS | 2019年 / 11卷
关键词
Bisphosphonate alendronate; Phytohormone; 8-prenylnaringenin; Vibration; Osteoporosis; Bone healing; Muscle;
D O I
10.1016/j.bonr.2019.100224
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bisphosphonate alendronate (ALN), phytoestrogen 8-prenylnaringenin (8-PN) and the whole body vibration exert a favorable effect on osteoporotic bone. However, the impact of these treatments and the combination of pharmacological therapies with biomechanical stimulation on muscle and bone has not yet been explored in detail. The effect of ALN and 8-PN and their combination with the vibration (Vib) on skeletal muscle and bone healing was investigated in ovariectomized (Ovx) rats. Three-month old rats were Ovx (n = 78), or left intact (Non-Ovx; n = 12). Five weeks after Ovx, all rats were treated according to the group assignment (n = 12/13): 1) Non-Ovx; 2) Ovx; 3) Ovx + Vib; 4) Ovx + ALN; 5) Ovx + ALN + Vib; 6): Ovx + 8-PN; 7) Ovx + 8-PN + Vib. Treatments with ALN (0.58 mg/kg BW, in food), 8-PN (1.77 mg/kg BW, daily s.c. injections) and/or with vertical vibration (0.5 mm, 35 Hz, 1 g, 15 min, 2x/day, 5x/week) were conducted for ten weeks. Nine weeks after Ovx, all rats underwent bilateral tibia osteotomy with plate osteosynthesis and were sacrificed six weeks later. Vibration increased fiber size and capillary density in muscle, enlarged callus area and width, and decreased callus density in tibia, and elevated alkaline phosphatase in serum. ALN and ALN + Vib enhanced capillarization and lactate dehydrogenase activity in muscle. In tibia, ALN slowed bone healing, ALN + Vib increased callus width and density, enhanced callus formation rate and expression of osteogenic genes. 8-PN and 8-PN + Vib decreased fiber size and increased capillary density in muscle; callus density and cortical width were reduced in tibia. Vibration worsened 8-PN effect on bone healing decreasing the callus width and area. Our data suggest that Vib, ALN, 8-PN, or 8-PN + Vib do not appear to aid bone healing. ALN + Vib improved bone healing; however application is questionable since single treatments impaired bone healing. Muscle responds to the anti-osteoporosis treatments and should be included in the evaluation of the drugs.
引用
收藏
页数:12
相关论文
共 14 条
  • [11] A single iv injection of equipotent doses of alendronate, risedronate, ibandronate and zoledronic acid exerts a bone protective effect of similar magnitude and duration in ovariectomized rats.
    Gasser, JA
    Ingold, P
    Green, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S307 - S307
  • [12] Combination therapy with ONO-KK1-300-01, a cathepsin K inhibitor, and parathyroid hormone results in additive beneficial effect on bone mineral density in ovariectomized rats
    Ochi, Yasuo
    Yamada, Hiroyuki
    Mori, Hiroshi
    Kawada, Naoki
    Tanaka, Makoto
    Imagawa, Akira
    Ohmoto, Kazuyuki
    Kawabata, Kazuhito
    JOURNAL OF BONE AND MINERAL METABOLISM, 2016, 34 (01) : 33 - 40
  • [13] Combination therapy with ONO-KK1-300-01, a cathepsin K inhibitor, and parathyroid hormone results in additive beneficial effect on bone mineral density in ovariectomized rats
    Yasuo Ochi
    Hiroyuki Yamada
    Hiroshi Mori
    Naoki Kawada
    Makoto Tanaka
    Akira Imagawa
    Kazuyuki Ohmoto
    Kazuhito Kawabata
    Journal of Bone and Mineral Metabolism, 2016, 34 : 33 - 40
  • [14] THE EFFECT ON VERTEBRAL BONE MASS AND STRENGTH OF LONG-TERM TREATMENT WITH ANTIRESORPTIVE AGENTS (ESTROGEN AND CALCITONIN), HUMAN PARATHYROID HORMONE-(1-38), AND COMBINATION THERAPY, ASSESSED IN AGED OVARIECTOMIZED RATS
    MOSEKILDE, L
    DANIELSEN, CC
    GASSER, J
    ENDOCRINOLOGY, 1994, 134 (05) : 2126 - 2134